Cytological DNA methylation for cervical cancer screening: a validation set.

Kong, Linghua; Wang, Linhai; Wang, Ziyun; Xiao, Xiaoping; You, Yan; Wu, Huanwen; Wu, Ming; Liu, Pei; Li, Lei

Kong, Linghua; Wang, Linhai; Wang, Ziyun; Xiao, Xiaoping; You, Yan; Wu, Huanwen; Wu, Ming; Liu, Pei; Li, Lei.

Afiliación

Kong L; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Beijing, China.
Wang L; Department of Technology, Beijing OriginPoly Biotechnology CO., Ltd., Beijing, China.
Wang Z; Department of Technology, Beijing OriginPoly Biotechnology CO., Ltd., Beijing, China.
Xiao X; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Beijing, China.
You Y; Department of Pathology, Peking Union Medical College Hospital, Beijing, China.
Wu H; Department of Pathology, Peking Union Medical College Hospital, Beijing, China.
Wu M; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Beijing, China.
Liu P; Department of Technology, Beijing OriginPoly Biotechnology CO., Ltd., Beijing, China.
Li L; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Beijing, China.

Front Oncol ; 13: 1181982, 2023.

Article en En | MEDLINE | ID: mdl-37671063

Palabras clave

DNA methylation; cervical cancer; cervical intraepithelial neoplasia; endometrial carcinoma; high-risk human papillomavirus; validation set

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google